| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/01/1995 | EP0640349A1 Vaccinal efficacy augmentor and efficacy-augmenting foods |
| 03/01/1995 | EP0640348A1 Oil-based and water-based adjuvant mixture |
| 03/01/1995 | EP0640347A1 Oral vaccine |
| 03/01/1995 | EP0640211A1 Method of preparing a diagnostic agent for detecting inflammations |
| 03/01/1995 | EP0640133A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 03/01/1995 | EP0640131A1 Genetically engineered antibodies |
| 03/01/1995 | EP0640129A1 Inhibition of cell adhesion protein-carbohydrate interactions |
| 03/01/1995 | EP0640128A1 Attenuated respiratory syncytial virus vaccine compositions |
| 03/01/1995 | EP0640101A1 Methods and reagents for diagnosis of autoantibodies |
| 03/01/1995 | EP0640100A1 Modulation of thrombospondin-cd36 interactions |
| 03/01/1995 | EP0640098A1 Canine coronavirus s gene and uses therefor |
| 03/01/1995 | EP0640097A1 Compositions and methods for vaccination against coronaviruses |
| 03/01/1995 | EP0640096A1 Universal coronavirus vaccine |
| 03/01/1995 | EP0640093A1 Human crabp-i and crabp-ii |
| 03/01/1995 | EP0639985A1 Method and composition for preserving antigens and process for utilizing cytological material produced by same |
| 03/01/1995 | EP0639977A1 Lipid-a analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities |
| 03/01/1995 | EP0520011B1 Vaccines for preventing furunculosis in fish |
| 03/01/1995 | EP0486609B1 Pharmaceutical product for the treatment of sepsis |
| 03/01/1995 | EP0363414B1 Use of a viral glycoprotein subunit vaccine for intranasal immunization against viral infection |
| 02/28/1995 | US5393523 Administering to protect against malaria |
| 02/26/1995 | CA2130612A1 Vaccinal efficacy augmentor and efficacy-augmenting foods |
| 02/23/1995 | WO1995005600A1 Methods of detecting and combating disorders of the central nervous system |
| 02/23/1995 | WO1995005463A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 02/23/1995 | WO1995005460A2 Feline immunodeficiency virus isolate ncsu 1 |
| 02/23/1995 | WO1995005454A1 Engineered bacteriophages and vaccines containing them |
| 02/23/1995 | WO1995005195A1 Pharmaceutical immunoadjuvant or immunostimulating compositions |
| 02/23/1995 | WO1995005194A1 Vaccine compositions |
| 02/23/1995 | WO1995005193A1 Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae |
| 02/23/1995 | DE4407538C1 Binding reagent for cell surface protein and effector cell |
| 02/23/1995 | CA2169289A1 Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae |
| 02/23/1995 | CA2169273A1 Methods of detecting and combating disorders of the central nervous system |
| 02/22/1995 | EP0639640A1 Poultry vaccine containing infections bronchitis virus serotype 4/91 |
| 02/22/1995 | EP0639225A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology |
| 02/22/1995 | EP0639081A1 Vaccine compositions for mucosal delivery |
| 02/22/1995 | EP0639080A1 Non-azo naphthalimide dyes and uses for same |
| 02/22/1995 | EP0639079A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 02/22/1995 | EP0639071A1 Water-in-oil fluid vaccinal emulsions containing a metabolizable oil |
| 02/22/1995 | EP0438401B1 Combination lock for blood identification system |
| 02/22/1995 | EP0229829B1 Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein |
| 02/21/1995 | US5391785 Partially protected alcohols, used to make phosphoramidites for modifying oligonucleotides |
| 02/21/1995 | US5391715 Contacting with a hydroxyapatite adsorbent; apolar-ligand chromatography |
| 02/21/1995 | US5391714 Polymorphism of human platelet membrane glycoprotein IIIA and diagnostic applications thereof |
| 02/21/1995 | US5391491 Avian embryo cell aggregate biomass for producing tick-born encephalitis virus/virus antigen |
| 02/21/1995 | CA1334513C Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
| 02/16/1995 | WO1995004827A1 Tick antigen |
| 02/16/1995 | WO1995004819A1 NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-β FAMILY |
| 02/16/1995 | WO1995004812A1 Hepatitis a virus culture process |
| 02/16/1995 | WO1995004755A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
| 02/16/1995 | WO1995004548A1 Prostatic cancer vaccine |
| 02/16/1995 | WO1995004547A1 POLYPEPTIDES CODED BY EXON v5 OF THE CD44 GENE AS TARGETS FOR IMMUNOTHERAPY AND IMMUNOSCINTIGRAPHY OF TUMOURS |
| 02/16/1995 | WO1995004546A1 Novel mutated human and simian immunodeficiency viruses and vaccines containing said viruses |
| 02/16/1995 | WO1995004545A1 Inactivated respiratory syncytial viral vaccines |
| 02/16/1995 | WO1995004542A1 Cloning and characterization of the complete mage-1 gene |
| 02/16/1995 | WO1995004524A1 A method for high loading of vesicles with biopolymeric substances |
| 02/16/1995 | WO1994029472A3 Mengovirus as a vector for expression of foreign polypeptides |
| 02/16/1995 | WO1994029451A3 Humanised antibodies |
| 02/16/1995 | WO1994026900A3 Hybrid picornaviruses expressing chlamydial epitopes |
| 02/16/1995 | CA2168988A1 Polypeptides coded by exon v5 of the cd44 gene as targets for immunotherapy and immunoscintigraphy of tumours |
| 02/16/1995 | CA2168952A1 Prostatic cancer vaccine |
| 02/16/1995 | CA2168582A1 Cloning and characterization of the complete mage-1 gene |
| 02/16/1995 | CA2168566A1 Method and reagent for inhibiting human immunodeficiency virus replication |
| 02/16/1995 | CA2145767A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
| 02/15/1995 | EP0638644A1 Receptors of interleukin-12 and antibodies |
| 02/15/1995 | EP0638316A1 Recombinant adenovirus vaccines |
| 02/15/1995 | EP0638175A1 In vitro test for helicobacter pylori |
| 02/15/1995 | EP0638126A1 Inhibitory factor |
| 02/15/1995 | EP0638124A1 Oral infection of insect larvae with pre-occluded baculovirus particles |
| 02/15/1995 | EP0638122A1 Cdna sequence of dengue virus serotype 1 (singapore strain) |
| 02/15/1995 | EP0638119A1 Chimeric receptor genes and cells transformed therewith |
| 02/15/1995 | EP0638092A1 Synthetic peptide vaccines for dental caries |
| 02/15/1995 | EP0638085A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 02/15/1995 | EP0638067A1 Novel propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels |
| 02/15/1995 | EP0637963A1 Cd28 pathway immunoregulation |
| 02/15/1995 | EP0637933A1 Method and kit for imaging and treating organs and tissues |
| 02/15/1995 | EP0587780B1 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 02/15/1995 | EP0524172B1 A method for isolating factor viii |
| 02/15/1995 | EP0389570B1 High integrity liposomes and method of preration and use |
| 02/15/1995 | EP0175787B1 RECOMBINANT HERPES SIMPLEX gB-gD VACCINE |
| 02/14/1995 | US5389540 Employing a DNA coding sequence having a (G+C) content that has been increased in the region from nucleotide 410 to the 3' end of the coding sequence relative to wild-type DNA sequence |
| 02/14/1995 | US5389530 Methods for the production of antibodies and induction of immune responses to tumor-associated ganagliosides by immunization with gangloiside lactones |
| 02/14/1995 | US5389528 Isolated DNA sequence encoding polypeptide identifiable as component of hepatitis delta antigen |
| 02/14/1995 | US5389520 Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 02/14/1995 | US5389518 Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof |
| 02/14/1995 | US5389368 Avirulent microbes and uses therefor |
| 02/14/1995 | CA1334388C Vaccine suitable for prophylaxis and control, respectively, of the pig disease caused by haemophilus pleuropneumoniae as well as a method for obtaining extracellular proteinaceuosmaterial of haemophilus pleuropneumoniae suitable for use in such vaccines |
| 02/14/1995 | CA1334387C Feline leukemia virus vaccine |
| 02/14/1995 | CA1334386C Method for producing hepatitis b virus proteins in yeast |
| 02/12/1995 | CA2130202A1 Recombinant adenovirus vaccines |
| 02/09/1995 | WO1995004282A1 Immunoassay for detecting collagen or collagen fragments |
| 02/09/1995 | WO1995004151A2 Vaccine compositions containing recombinant tetc-fusion proteins |
| 02/09/1995 | WO1995004147A1 Recombinant constructs using replacement sequences in hypervariable regions |
| 02/09/1995 | WO1995004145A1 Novel b. burgdorferi polypeptides |
| 02/09/1995 | WO1995004133A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
| 02/09/1995 | WO1995004081A1 MONOCLONAL IgA ANTIBODY AGAINST RESPIRATORY SYNCYTIAL VIRUS |
| 02/09/1995 | WO1995004080A1 Human antibodies against varicella-zoster virus |
| 02/09/1995 | WO1995004079A1 Recombinant vector containing a lipoprotein gene sequence for expressing nucleotide sequences |
| 02/09/1995 | WO1995004064A1 Polynucleotide decoys that ihnibit mhc-ii expression and uses thereof |
| 02/09/1995 | WO1995003832A1 Intracellular immunization |
| 02/09/1995 | WO1995003827A1 Method for treating multiple sclerosis |
| 02/09/1995 | WO1995003826A1 Stabilised immunoglobulin preparations and method for preparing same |